Want us to feature your writing?
We are looking for more great writers to feature here. Send us a submission and we'll be in touch!Send your Writing!
Dr. Harry C. Hwang is the Director of Molecular Pathology and Pathologist at PhenoPath Laboratories, PLLC in Seattle, Washington. He received his Doctor of Medicine (M.D.) at the University of Pennsylvania School of Medicine, Philadelphia, PA. He was a resident at the Department of Pathology (AP/CP), University of Washington, School of Medicine and completed a Fellowship in Diagnostic Immunohistochemistry at PhenoPath Laboratories, PLLC both in Seattle, WA. He is a board certified Clinical and Anatomical Pathologist. Dr. Hwang is involved in molecular as well as immunohistochemical based diagnoses at PhenoPath. Most recently, he is a author and co-author on published research articles investigating the role of BAP1 IHC and P16 FISH in the evaluation of mesothelial proliferations and mesothelioma titled, 'p16 FISH Deletion in Surface Epithelial Mesothelial Proliferations Is Predictive of Underlying Invasive Mesothelioma' Am J Surg Pathol. May 2014 and ‘BAP1 Immunohistochemistry and p16 FISH to Separate Benign From Malignant Mesothelial Proliferations’. Am J Surg Pathol. July 2015.